Chandler Robinson

Chief Executive Officer, Director, Monopar Therapeutics

Bought, 12 months

$0.0M

Sold, 12 months

$2.6M

Companies

Latest trade

Sep 24, 2026

Companies

Monopar TherapeuticsChief Executive Officer, Director −$2.6M

Trades

MNPR Sold 29,056 shares at $88.00 · planned $2.6M Sep 24

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.